HIGHLIGHTS
- who: V. Konduri from the Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA have published the paper: Dendritic cell vaccination plus low-dose doxorubicin for the treatment of spontaneous canine hemangiosarcoma, in the Journal: (JOURNAL)
- what: The authors report the analysis of a pilot phase I open-label trial of chemo-immunotherapy performed on consecutively presenting splenectomized canines with histologically verified HSA. This work has demonstrated that the loading of DC with antigenically similar (homologous) MHC class I and II antigens mediates a cellintrinsic upregulation of TH1 polarization. The aim of . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.